Latest Strategy Changes News

SkyCity Entertainment Group reported a decline in FY25 revenue and earnings but remains confident in its FY26 outlook, underpinned by cost savings and strategic initiatives.

Firebird Metals has advanced its manganese-rich battery materials strategy with new Chinese patents, a significant kiln sales interest, and a A$6 million capital raise, alongside key leadership changes.

Group One Capital Limited reports initial $600,000 fee income from its subsidiary FSU Capital, with a $16 million fee pipeline and refreshed board governance signaling strategic momentum.

Korab Resources has completed key geophysical surveys at its Rum Jungle Project and progressed pre-feasibility studies for magnesium products, while navigating ASX suspension and pursuing asset divestments.

Waratah Minerals reported a net cash outflow of AUD 3.4 million from operations in Q3 2025 but bolstered its liquidity with AUD 12.2 million raised through financing activities, ending the quarter with AUD 16.1 million in cash.

Brockman Mining Limited reports steady progress on its Marillana and Ophthalmia iron ore projects through joint ventures and infrastructure planning, maintaining a solid cash position despite no production this quarter.

Krakatoa Resources has launched a major drilling campaign at its Zopkhito Antimony-Gold Project in Georgia, backed by a $3.1 million capital raise, while also expanding its rare earths landholding in Western Australia.

Platina Resources has accelerated its exploration ambitions in Western Australia's Laverton gold district, acquiring the Mt McKenna Project and entering a conditional agreement for Sunrise Bore, while advancing multiple drilling programs.

TT Investments has extended its unconditional takeover offer for 360 Capital Group securities to 13 November 2025, maintaining a substantial premium and signaling potential strategic shifts post-acquisition.

Orpheus Uranium has advanced its exploration agenda by finalizing multiple Native Title Mining Agreements across South Australia and the Northern Territory, while strategically acquiring the Oobagooma Project in Western Australia to diversify its uranium asset base.

Far East Gold reports a productive September quarter with significant drilling results at its Idenburg Project, including a new high-grade discovery at North Bermol and an expanded pipeline of exploration targets.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.